Search research articles
Contact Us
Filters
Showing results (71-80 of 177) with videos related to
Page
of 18
Sort By:
Antimicrobial Agents and Chemotherapy
|
May 30, 2013
Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model
Hee Ji Lee, Phillip J Bergen, Jurgen B Bulitta, et al.
International Journal of Antimicrobial Agents
|
October 30, 2016
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Thien B Tran, Tony Velkov, Roger L Nation, et al.
Journal of Clinical Pharmacology
|
November 10, 2018
Definition and Validation of a Novel Metric of Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients
Calvin J Meaney, Spinel Karas, Ben Robinson, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2009
Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia
Yoriko Harigaya, Jürgen B Bulitta, Alan Forrest, et al.
Current Pharmaceutical Biotechnology
|
May 11, 2011
Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patients
Jurgen B Bulitta, Cornelia B Landersdorfer, Alan Forrest, et al.
Biopharmaceutics & Drug Disposition
|
November 29, 2007
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers
Qing Ma, Alan Forrest, Susan L Rosenkranz, et al.
The Journal of Antimicrobial Chemotherapy
|
November 29, 2007
Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia
Pamela A Moise, Davida S Smyth, Nadia El-Fawal, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 2018
Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body Sizes
Elizabeth A Lakota, Cornelia B Landersdorfer, Li Zhang, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
May 7, 2013
Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia
Vidya Perera, Annette S Gross, Thomas M Polasek, et al.
Scientific Reports
|
March 31, 2017
Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii
Mohd Hafidz Mahamad Maifiah, Darren J Creek, Roger L Nation, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 177) with videos related to
Sort By:
Page
of 18
Antimicrobial Agents and Chemotherapy
|
May 30, 2013
Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model
Hee Ji Lee, Phillip J Bergen, Jurgen B Bulitta, et al.
International Journal of Antimicrobial Agents
|
October 30, 2016
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Thien B Tran, Tony Velkov, Roger L Nation, et al.
Journal of Clinical Pharmacology
|
November 10, 2018
Definition and Validation of a Novel Metric of Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients
Calvin J Meaney, Spinel Karas, Ben Robinson, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2009
Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia
Yoriko Harigaya, Jürgen B Bulitta, Alan Forrest, et al.
Current Pharmaceutical Biotechnology
|
May 11, 2011
Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patients
Jurgen B Bulitta, Cornelia B Landersdorfer, Alan Forrest, et al.
Biopharmaceutics & Drug Disposition
|
November 29, 2007
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers
Qing Ma, Alan Forrest, Susan L Rosenkranz, et al.
The Journal of Antimicrobial Chemotherapy
|
November 29, 2007
Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia
Pamela A Moise, Davida S Smyth, Nadia El-Fawal, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 2018
Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body Sizes
Elizabeth A Lakota, Cornelia B Landersdorfer, Li Zhang, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
May 7, 2013
Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia
Vidya Perera, Annette S Gross, Thomas M Polasek, et al.
Scientific Reports
|
March 31, 2017
Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii
Mohd Hafidz Mahamad Maifiah, Darren J Creek, Roger L Nation, et al.
Page
of 18